Cleared Traditional

K800925 - VERIFY S PROD. #34141

K800925 is the FDA 510(k) clearance for VERIFY S PROD. #34141 by General Diagnostics. It is a Class 2 Hematology device (product code GGW) cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K800925 · General Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1980
Decision
91d
Days
Class 2
Risk

K800925 is an FDA 510(k) clearance for the VERIFY S PROD. #34141. Classified as Test, Time, Partial Thromboplastin (product code GGW), Class II - Special Controls.

Submitted by General Diagnostics (Mchenry, US). The FDA issued a Cleared decision on July 21, 1980 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7925 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all General Diagnostics devices

Submission Details

510(k) Number K800925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 1980
Decision Date July 21, 1980
Days to Decision 91 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 113d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GGW Test, Time, Partial Thromboplastin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7925
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGW Test, Time, Partial Thromboplastin

All 20
Devices cleared under the same product code (GGW) and FDA review panel - the closest regulatory comparables to K800925.
ACTIN FS ACTIVATED PTT REAGENT
K811589 · American Dade · Jul 1981
AB-TROL COAGULATION CONTROL
K802232 · Helena Laboratories · Nov 1980
HEP-TROL
K801932 · Helena Laboratories · Sep 1980
ANTIBODY TO VARICELLA-ZOSTER VIRUS
K800787 · Electro-Nucleonics Laboratories, Inc. · Jul 1980
A-GENT QUANTICHROM THROMBIGEN I
K800725 · Abbott Laboratories · Jun 1980
LANCER COAGENT APTT KIT
K792048 · Sherwood Medical Co. · Nov 1979